We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+26.12%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$9.62M
Cap. Flow
-$11.4M
Cap. Flow %
-10.58%
Top 10 Hldgs %
65.66%
Holding
39
New
8
Increased
9
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
ALIM
Alimera Sciences
ALIM
+$3.22M
2
IMGN
Immunogen Inc
IMGN
+$2.24M
3
ANNX icon
Annexon
ANNX
+$1.57M
4
NSPR icon
InspireMD
NSPR
+$1.44M
5
GERN icon
Geron
GERN
+$1.36M

Top Sells

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$9.89M
2
ADMA icon
ADMA Biologics
ADMA
+$4.72M
3
LNTH icon
Lantheus
LNTH
+$4.49M
4
TERN
Terns Pharmaceuticals
TERN
+$1.42M
5
PNT
POINT Biopharma Global Inc. Common Stock
PNT
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 98.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
26
Rezolute
RZLT
$453M
$792K 0.74%
400,000
– –
ELEV
27
DELISTED
Elevation Oncology
ELEV
$756K 0.7%
+497,299
New +$1.31M
INBX
28
DELISTED
Inhibrx, Inc. Common Stock
INBX
$649K 0.6%
+25,000
New +$584K
AIRS icon
29
CALL
AirSculpt Technologies
AIRS
$234M
$647K 0.6%
+75,000
New +$490K
CGEM icon
30
Cullinan Oncology
CGEM
$1.26B
$538K 0.5%
+50,000
New +$531K
QIPT
31
CALL
DELISTED
Quipt Home Medical
QIPT
$534K 0.5%
+100,000
New +$590K
BOLT icon
32
Bolt Biotherapeutics
BOLT
$6.63M
– –
-7,000
Closed -$195K
COLL icon
33
Collegium Pharmaceutical
COLL
$834M
– –
-22,095
Closed -$530K
FEZ icon
34
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
– –
-100,000
Closed -$4.49M
IMCR icon
35
Immunocore
IMCR
$1.77B
– –
-200,000
Closed -$9.89M
IRON icon
36
Disc Medicine
IRON
$3.09B
– –
-12,269
Closed -$260K
SNDA icon
37
Sonida Senior Living
SNDA
$1.88B
– –
-82,832
Closed -$562K
TERN
38
DELISTED
Terns Pharmaceuticals
TERN
– –
-120,000
Closed -$1.42M
THRX
39
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-100,000
Closed -$888K
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Velan Capital Investment Management held 39 positions worth $108M, down 8.2% from $117M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Velan Capital Investment Management withdrew a net $11.4M in Q2 2023, closing 8 positions and reducing 4 holdings. Its most notable exit was Immunocore, an estimated $9.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 96% a quarter earlier.

Against the trend, Velan Capital Investment Management opened a new position in Immunogen Inc worth $3.58M.

  • Velan Capital Investment Management's largest Q2 2023 buy was Immunogen Inc: 189,500 shares worth $3.58M.
  • Velan Capital Investment Management added most to Alimera Sciences in Q2 2023, an estimated $3.22M increase.
  • Velan Capital Investment Management's biggest Q2 2023 reduction was ADMA Biologics, cutting an estimated $4.72M.
  • Velan Capital Investment Management fully exited Immunocore in Q2 2023, selling an estimated $9.89M.
  • Velan Capital Investment Management's ten largest holdings make up 66% of its $108M portfolio in Q2 2023.
  • Velan Capital Investment Management opened 8 new positions and closed 8 in Q2 2023.
  • Velan Capital Investment Management's portfolio value fell 8.2% quarter-over-quarter to $108M.

Based on Velan Capital Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.